Skip to main content



Let's help beat COVID-19 for all - download the COVID Symptom Tracker

The COVID Symptom Tracker developed by ZOE Global Limited, alongside King's College London, to study the symptoms and spread of COVID-19, have now partnered with the UK's leading charities and all of the Royal Medical Colleges, to better understand the virus in those who are more vulnerable. To help support this important initiative, more volunteers are needed to take part.
BTK Inhibitors

BTK inhibitors – do they have a role to play in reducing the impact of COVID-19?

Research amongst WM patients with COVID-19 shows interesting findings.
There is a suggestion that BTK inhibitors such as ibrutinib, acalabrutinib and zanubrutinib may provide favourable suppression of the immune system resulting in the reduction of inflammatory damage to the lungs due to COVID-19 - the so-called cytokine release syndrome (CRS).

Welcome to our new website!

As part of our ongoing commitment to support people with WM and their families, WMUK are proud to announce the launch of our newly redesigned website for the WM community.